Takamatsu T, Yamazaki K, Kayano M, Takenaka F, Hasui M, Ohkawa T
Department of Clinical Chemistry, Tokyo Research Laboratories, Eisai Co., Ltd., Tokyo, Japan.
J Chromatogr. 1992 Dec 23;584(2):261-6. doi: 10.1016/0378-4347(92)80584-d.
A gas chromatographic-mass spectrometric method was developed to determine eperisone hydrochloride, 4'-ethyl-2-methyl-3-piperidinopropiophenone hydrochloride, in human plasma over the concentration range 0.2-40 ng/ml. Excellent sensitivity was achieved by selection of a favorable fragment ion, m/z 98, of eperisone and reduction of heat decomposition of eperisone by using a splitless injector and a shortened capillary column. The method described here allows the determination of plasma concentrations as low as 0.2 ng/ml, the concentration attained 6 h after a single oral administration of 50 mg. At eperisone hydrochloride concentrations higher than 0.5 ng/ml, the mean inter-day variation of accuracy of the assay was less than 12%.
建立了一种气相色谱 - 质谱法,用于测定人血浆中盐酸乙哌立松(4'- 乙基 - 2 - 甲基 - 3 - 哌啶基苯丙酮盐酸盐),浓度范围为0.2 - 40 ng/ml。通过选择盐酸乙哌立松的有利碎片离子m/z 98,并使用不分流进样器和缩短的毛细管柱减少盐酸乙哌立松的热分解,实现了出色的灵敏度。本文所述方法能够测定低至0.2 ng/ml的血浆浓度,这是单次口服50 mg后6小时达到的浓度。在盐酸乙哌立松浓度高于0.5 ng/ml时,该测定方法准确度的日间平均变异小于12%。